Personalized medicine can save millions of
Recently available personalized cell and gene therapies have groundbreakingly
improved the chances of recovery for cancer patients.
Pharmaceutical companies will conduct increasing numbers of personalized therapy studies and hospitals want to offer these life-saving therapies to their patients as soon as possible.
Xencura‘s innovative products will enable them to manufacture personalized therapeutics at the point of care, thereby reducing the costs of goods and time to market.
A digital transformation process is required at
the hospital to achieve this goal.
To enable broad clinical use of personalized cell and gene therapeutics, the entire treatment process must be fully traceable through standardization and digitization of all necessary processes from diagnosing the disease to the production of the personalized therapeutic itself to the subsequent therapy.
With the use of the Internet of Things (IoT), Xencura enables optimization of
procedures through direct communication between devices, systems, materials
and people.
Only a well-coordinated technological ecosystem can master all interdisciplinary challenges.
To solve the challenges of personalized medicine, the entire value chain must be utilized and not restricted by company boundaries.
Xencura brings together an ecosystem of autonomous players who support each other and create optimal market conditions for their products.
As a development company, Xencura focuses on (bio) technological, digital and medical innovations that enable an “Economy of Scale”.